Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.

Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.

The anti-carbamylated protein (CarP) antibody is a novel biomarker that might help in the diagnosis of rheumatoid arthritis (RA). We aim to assess the diagnostic value of anti-CarP antibody for RA.We systematically searched PubMed, Embase, the Cochrane Library, Web of Science, and Scopus for studies...

Full description

Bibliographic Details
Main Authors:	Liubing Li, Chuiwen Deng, Si Chen, Shulan Zhang, Ziyan Wu, Chaojun Hu, Fengchun Zhang, Yongzhe Li
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4954701?pdf=render

Similar Items

Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis
by: Shuichiro Nakabo
Published: (2019-01-01)

Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of Sjögren syndrome.
by: Chuiwen Deng, et al.
Published: (2015-01-01)

Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis
by: Vincent Ricchiuti, et al.
Published: (2022-07-01)

Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.
by: Ariana Montes, et al.
Published: (2016-01-01)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
by: Liam J. O’Neil, et al.
Published: (2021-09-01)

Detection and clinical significance of anti-carbamylated protein antibody in serologically negative patients with rheumatoid arthritis
by: Wu Tao, Chen Chutao, Yang Lijuan, Zou Yaowei, Ma Jianda, Xu Yanhui, Jia Lei, Dai Lie
Published: (2022-04-01)

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
by: Raul Castellanos-Moreira, et al.
Published: (2020-12-01)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
by: Myrthe A. M. van Delft, et al.
Published: (2017-08-01)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
by: Chao-Yi Wu, et al.
Published: (2021-01-01)

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
by: Francesca Romana Spinelli, et al.
Published: (2017-05-01)

Diagnostic Accuracy of IL-17A/IL-17F Gene Polymorphism and Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis: Meta-analysis Study (2014-2020)
by: Samar Sayed Ahmed, et al.
Published: (2023-01-01)

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.
by: Laura Vidal-Bralo, et al.
Published: (2017-01-01)

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
by: Shomi Oka, et al.
Published: (2022-01-01)

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
by: Cristina Regueiro, et al.
Published: (2021-05-01)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
by: Cristina Regueiro, et al.
Published: (2017-09-01)

Evaluation of anti-carbamylated protein antibodies as a potential biomarker in assisting the diagnosis of rheumatoid arthritis and its correlation with disease activity
by: Othman, Maizatul Akmal
Published: (2018)

Anti-carbamylated protein antibodies in systemic sclerosis
by: Sophie I. E. Liem, et al.
Published: (2023-07-01)

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis
by: Marije K. Verheul, et al.
Published: (2017-11-01)

Citrullination and carbamylation in the pathophysiology of rheumatoid arthritits
by: Ger J.M. Pruijn
Published: (2015-04-01)

Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation
by: Eui-Jong Kwon, et al.
Published: (2021-09-01)

Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.
by: Yufeng Yin, et al.
Published: (2014-01-01)

Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
by: Cristina Regueiro, et al.
Published: (2018-01-01)

Research progress on anti-carbamylated protein antibodies in connective tissue disease
by: Dong Rongrong, Yang Qingrui, Ma Zhenzhen
Published: (2023-04-01)

Diagnostic value of Anti-CCP antibodies compared with Rheumatoid factor in Rheumatoid arthritis patients.
by: Hanaa N. Abdullah, et al.
Published: (2013-08-01)

Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis.
by: Jeroen N Stoop, et al.
Published: (2014-01-01)

Anti-CCP antibodies: A Better Diagnostic Tool for Rheumatoid Arthritis
by: Hussin, Che Maraina Che
Published: (2009)

Do anti-carbamylated protein antibodies in rheumatoid arthritis reflect local and systemic osteoporosis? A study of osteoprotegrin and receptor activator for nuclear factor kappa B ligand and radiological assessment
by: Manal Shawky Hussein, et al.
Published: (2021-03-01)

The status of rheumatoid factor and anti-cyclic citrullinated peptide antibody are not associated with the effect of anti-TNFα agent treatment in patients with rheumatoid arthritis: a meta-analysis.
by: Qianwen Lv, et al.
Published: (2014-01-01)

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association.
by: Elvira Favoino, et al.
Published: (2018-01-01)

Distribution and clinical significance of anti-carbamylation protein antibodies in rheumatological diseases among the Chinese Han population
by: Rongrong Dong, et al.
Published: (2023-07-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: The predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis
by: Heidari Behzad, et al.
Published: (2009-01-01)

Anti-chromatin antibodies in juvenile rheumatoid arthritis
by: F. Ingegnoli, et al.
Published: (2003-12-01)

Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis
by: Xiaochun Yang, et al.
Published: (2021-09-01)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
by: Theodoridou Katerina, et al.
Published: (2007-04-01)

Diagnostic utility of Anti-cyclic Citrullinated Peptide Antibodies for Very Early Rheumatoid Arthritis
by: Sucilathangam G, et al.
Published: (2014-07-01)

Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis
by: G.L. Erre, et al.
Published: (2004-06-01)

Diagnostic effectiveness of anti-citrullinated peptides antibodies of second and third generations for rheumatoid arthritis
by: Goitybell Martínez Téllez, et al.
Published: (2018-08-01)

Diagnostic Accuracy of Anticarbamylated Protein Antibodies in Established Rheumatoid Arthritis: A Monocentric Cross‐Sectional Study
by: G. L. Erre, et al.
Published: (2019-09-01)

Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus
by: Fulvia Ceccarelli, et al.
Published: (2018-06-01)